ArticleRMD open2018

Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial.

Lena Bugge Nordberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.